Thioamide-modified peptides and uses thereof
US11891425B2 · kind B2 · utility
0Cited by
2References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 12, 2021 |
| Grant date | Feb 6, 2024 |
| Priority date | — |
| Expiry date | Sep 26, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention includes a thioamide-modified peptide, wherein the thioamide modification increases the in vivo half-life of the peptide. The invention further includes methods of treating or preventing a disease or disorder in a subject in need thereof, the method comprising administering to the subject a thioamide-modified peptide of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.